E
Elena Zotenko
Researcher at Garvan Institute of Medical Research
Publications - 39
Citations - 2756
Elena Zotenko is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: DNA methylation & Cancer. The author has an hindex of 19, co-authored 35 publications receiving 2139 citations. Previous affiliations of Elena Zotenko include Max Planck Society & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling
Ruth Pidsley,Ruth Pidsley,Elena Zotenko,Elena Zotenko,Tim J Peters,Mitchell G. Lawrence,Gail P. Risbridger,Peter L. Molloy,Susan Van Djik,Beverly S. Muhlhausler,Clare Stirzaker,Clare Stirzaker,Susan J. Clark,Susan J. Clark +13 more
TL;DR: The EPIC array is a significant improvement over the HM450 array, with increased genome coverage of regulatory regions and high reproducibility and reliability, providing a valuable tool for high-throughput human methylome analyses from diverse clinical samples.
Journal ArticleDOI
Why do hubs in the yeast protein interaction network tend to be essential: reexamining the connection between the network topology and essentiality.
TL;DR: A rigorous analysis of six variants of the genomewide protein interaction network for Saccharomyces cerevisiae demonstrated that the majority of hubs are essential due to their involvement in Essential Complex Biological Modules, a group of densely connected proteins with shared biological function that are enriched in essential proteins.
Journal ArticleDOI
Three-dimensional disorganization of the cancer genome occurs coincident with long-range genetic and epigenetic alterations
Phillippa C. Taberlay,Joanna Achinger-Kawecka,Aaron T. L. Lun,Fabian A. Buske,Kenneth S. Sabir,Cathryn M. Gould,Elena Zotenko,Saul A. Bert,Katherine A. Giles,Denis C. Bauer,Gordon K. Smyth,Clare Stirzaker,Seán I. O'Donoghue,Susan J. Clark +13 more
TL;DR: It is found that cancer cells retain the ability to segment their genomes into megabase-sized topologically associated domains (TADs); however, these domains are generally smaller due to establishment of additional domain boundaries.
Journal ArticleDOI
Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value.
Clare Stirzaker,Elena Zotenko,Jenny Z. Song,Wenjia Qu,Shalima S. Nair,Warwick J. Locke,Andrew Stone,Nicola J. Armstong,Mark D. Robinson,Alexander Dobrovic,Kelly A. Avery-Kiejda,Kate M. Peters,Juliet D. French,Sandra Stein,Darren Korbie,Matt Trau,John F. Forbes,Rodney J. Scott,Melissa A. Brown,Glenn Francis,Susan J. Clark +20 more
TL;DR: The data reveal that coordinated hypermethylation can occur in oestrogen receptor-negative disease, and that characterizing the epigenetic framework provides a potential signature to stratify TNBCs, demonstrating the feasibility of profiling the cancer methylome with limited archival tissue to identify regulatory regions associated with cancer.
Journal ArticleDOI
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer
Andrew Stone,Andrew Stone,Elena Zotenko,Elena Zotenko,Warwick J. Locke,Warwick J. Locke,Darren Korbie,Ewan K.A. Millar,Ruth Pidsley,Ruth Pidsley,Clare Stirzaker,Clare Stirzaker,Peter Graham,Peter Graham,Matt Trau,Elizabeth A. Musgrove,Elizabeth A. Musgrove,Elizabeth A. Musgrove,Robert Ian Nicholson,Julia Margaret Wendy Gee,Susan J. Clark,Susan J. Clark +21 more
TL;DR: The DNA methylome of endocrine sensitivity is characterized and the potential impact of differential DNA methylation on endocrine response in breast cancer is demonstrated, showing that DNA hypermethylation occurs predominantly at oestrogen-responsive enhancers and is associated with reduced ESR1 binding and decreased gene expression of key regulators of E SR1 activity.